Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
BUSINESS
Mitsubishi Tanabe, Alfresa Obtain Approval for Additional Indication for Sleep Disorder Treatment Modiodal
Mitsubishi Tanabe Pharma and Alfresa Pharma, a subsidiary of Alfresa Holdings, announced on November 25 that they had obtained approval for an additional indication for their comarketed sleep disorder treatment Modiodal Tablets 100 mg (modafinil). The new indication, approved for…
To read the full story
BUSINESS
- Nipro Eyes 50-60 Stemirac Treatment Sites across Japan after Full Nod
November 20, 2026
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- Japan Drug Makers’ Sales Seen Dipping in FY2026 on Co-Marketing Exits
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026





